Next-Generation Sequencing (NGS) is becoming a hot topic in diagnostics. But how is the data generated and processed so it can be used to develop diagnostic tests? We speak to Michael Schmid, founder of Genexa, a bioinformatics start-up that has worked with EU-based labs to solve these problems.